GERD Diagnosis: When to Stop PPIs and Scope

Diagnosing GERD Beyond PPI Trials

• 🎯 Positive diagnosis of GERD is key to justifying lifelong PPI therapy for patients who truly need it.
• 💡 If symptoms improve on an 8-week PPI trial and don't recur after stopping, the patient likely doesn't need further evaluation for GERD.
• ⚠️ If symptoms recur or are not managed on PPIs, stop the PPI for two weeks before an endoscopy to allow erosive changes to remanifest.

Endoscopic and pH Monitoring Evaluation

• 🔬 Upper endoscopy can identify erosive changes, Barrett's esophagus, or severe esophagitis, warranting continued PPI therapy.
• 🧪 If endoscopy shows no erosive evidence, wireless pH monitoring can help confirm GERD by assessing acid exposure time.
• 📈 Patients with zero or one day of acid exposure time over 4 days may still benefit from PPIs, potentially due to reflux hypersensitivity.

Reflux Hypersensitivity and Functional Heartburn

• 🧠 Reflux hypersensitivity describes individuals who feel heartburn symptoms more intensely even with minimal or intermittent acid exposure.
• ❓ Functional heartburn presents with heartburn symptoms but no detectable cause, often managed by gastroenterologists.

Long-Term PPI Therapy and Potential Risks

• 📌 Lifelong PPI therapy is typically reserved for patients with complications like strictures, Barrett's, or high-grade esophagitis.
• ⚠️ While concerns exist about PPIs causing dementia, osteoporosis, and CKD, the evidence is largely associational rather than causal.
• ⚡ The most substantiated risk of PPIs is an increased likelihood of enteric infections.
• 🔍 Micronutrient deficiencies, such as B12 and magnesium, are also monitored with long-term PPI use, though catastrophic effects are not commonly borne out.